Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06578429 · ClinicalTrials.gov registry record · NA

Deep TMS of Neural Circuits Associated With Stimulant Use Disorder

A NA study of Methamphetamine Use Disorder and Transcranial Magnetic Stimulation, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06578429 is a NA study of Methamphetamine Use Disorder and Transcranial Magnetic Stimulation that is actively recruiting participants, run by Stanford University. The registered enrollment target is 30 participants, below the 53-participant average among 12 other Methamphetamine Use Disorder trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06578429, a NA study of Methamphetamine Use Disorder and Transcranial Magnetic Stimulation, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with a methamphetamine use disorder (MUD).

Interventions

  • DEVICE Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Active
  • DEVICE Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Sham

Study Locations (1)

California

  • VA Palo Alto Health Care System - Palo Alto

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-03-15
Est. Completion 2026-12-31
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT06578429

The ClinicalTrials.gov registry entry for NCT06578429 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 53-participant average among 12 other Methamphetamine Use Disorder trials with a reported enrollment target (43% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Methamphetamine Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Active is the first listed.

NCT06578429 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06578429 about?

NCT06578429 is a clinical study titled "Deep TMS of Neural Circuits Associated With Stimulant Use Disorder". This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with a methamphetamine use disorder (MUD).

What is the current status of trial NCT06578429?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-15. Estimated completion is 2026-12-31.

What conditions does trial NCT06578429 study?

This clinical trial studies the following conditions: Methamphetamine Use Disorder, Transcranial Magnetic Stimulation.

What interventions are being tested in trial NCT06578429?

The interventions under investigation include: Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Active (DEVICE), Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Sham (DEVICE).

Who is sponsoring clinical trial NCT06578429?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06578429 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Methamphetamine Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.